Unichem Laboratories Ltd

Unichem Laboratories Ltd

$UNICHEMLABPharmaceuticalsNSEBSE

Unichem Laboratories Ltd (UNICHEMLAB) last traded at ₹536, a market capitalisation of ₹3,770 crore, on a P/E of 30.8. Over the past 52 weeks the stock has ranged between ₹278 and ₹687. Unichem Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹633 crore and net profit of ₹41 crore. Figures are as of 25 Aug 2026 and are not real time.

Unichem Laboratories Ltd share price and key metrics

Current price
₹536
Market cap
₹3,770 cr
Stock P/E
30.8
Book value
₹386
ROE
3.17%
ROCE
4.13%
Dividend yield
0.00%
52w high / low
687/278

Metrics as of 25 Aug 2026. Not real time.

Unichem Laboratories Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹633 cr, up 20.1% from ₹527 cr a year earlier. Net profit turned positive at ₹41 cr.

Unichem Laboratories Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales507533587527579521575633
Expenses452448503504513476527563
Operating profit5586842266454870
OPM %11%16%14%4.3%11%9%8%11%
Other income91497-372871116
Interest57578797
Depreciation3231303231313130
Profit before tax276258-9-112931949
Tax %9%6%8%16%10%10%42%15%
Net profit255853-10-122641141
EPS (₹)3.508.227.52-1.49-1.6937.541.555.89

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Unichem Laboratories Ltd annual results

Unichem Laboratories Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,2351,2701,3431,7852,1112,2022,308
Operating profit9172-4687265189229
OPM %7%6%-3.4%4.9%13%9%10%
Net profit3433-202-94138253305
EPS (₹)4.874.70-28.72-13.3219.5335.9143.29

TTM is the trailing twelve months to the most recent quarter.

Unichem Laboratories Ltd growth and returns

Compounded Sales Growth
10 Years
5%
5 Years
12%
3 Years
18%
TTM
7%
Compounded Profit Growth
10 Years
-3%
5 Years
25%
3 Years
35%
TTM
-2%
Stock Price CAGR
10 Years
6%
5 Years
13%
3 Years
7%
1 Year
0%
Return on Equity
10 Years
11%
5 Years
0%
3 Years
2%
Last Year
3%

Unichem Laboratories Ltd shareholding pattern

Promoters held 70.22% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.90% and DIIs 10.46%.

Unichem Laboratories Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%
FIIs0.94%1.05%0.98%0.98%0.99%0.99%1.00%0.90%
DIIs11.65%11.63%11.32%10.92%10.74%10.73%10.63%10.46%
Public17.17%17.11%17.47%17.88%18.04%18.05%18.14%18.41%
No. of shareholders20,37421,47221,62123,01023,57723,26723,38625,347

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Unichem Laboratories Ltd corporate filings

  • Disclosure of Voting Results alongwith Scrutinizer''s Report dated 12th August 2026.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Unichem Laboratories Limited has successfully concluded its 63rd Annual General Meeting…

    Read the full analysis
  • Financial Results for the quarter ended June 30, 2026, published in the newspapers on August 12, 2026.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Unichem Laboratories Limited has released its unaudited financial results for the quarter…

    Read the full analysis
  • Proceedings of the 63rd Annual General Meeting.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Unichem Laboratories Ltd. has successfully concluded its 63rd Annual General Meeting held…

    Read the full analysis
  • Unaudited Financial Statements (Consolidated & Standalone) for the first quarter ended 30th June 2026 alongwith Limited Review report by AuditorsBoard Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Unichem Laboratories Limited has reported a significant financial turnaround for the…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Unichem Laboratories Ltd

Cruxal reads every Unichem Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Unichem Laboratories Ltd (UNICHEMLAB) Results, Financials & Share Price | Cruxal